V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006462 | 200014867 | null | 51.85 | Adjuvant (A) | 2020-01-14 | 2020-01-16 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100324638 |
| 200006465 | 200014869 | 1.68 | 61.5 | null | 2018-01-16 | 2018-01-26 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100763139 |
| 200006468 | 200014871 | 1.69 | 63.95 | Palliative (P) | 2019-09-30 | 2019-10-03 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101776673 |
| 200006470 | 200014872 | 1.62 | 76.6 | null | 2020-08-30 | 2020-12-25 | Ipilimumab | 02 | null | IPILIMUMAB | 100381565 |
| 200006477 | 200014876 | null | null | null | null | 2020-03-23 | null | null | null | TALIMOGENE LAHERPAREPVEC | 101631635 |
| 200006478 | 200014877 | 1.77 | 85 | Palliative (P) | 2016-07-14 | 2016-07-14 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | DABRAFENIB | 100814353 |
| 200006480 | 200014878 | 1.69 | 82.4 | Palliative (P) | 2019-08-06 | 2019-08-13 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100695170 |
| 200006481 | 200014879 | null | 68 | Palliative (P) | 2018-12-21 | 2019-02-02 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101526265 |
| 200006485 | 200014881 | null | 67 | null | 2021-05-01 | 2021-05-02 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100422269 |
| 200006488 | 200014882 | 1.82 | 65.3 | Palliative (P) | 2021-01-17 | 2021-05-29 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100129149 |
| 200006490 | 200014883 | 1.6 | 81 | Palliative (P) | null | 2020-01-05 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101102963 |
| 200006491 | 200014884 | 1.8 | 74 | Palliative (P) | null | 2017-07-26 | null | null | N | TRIAL | 100120109 |
| 200006494 | 200014887 | 1.56 | 91.3 | Palliative (P) | null | 2019-01-12 | null | null | null | DACARBAZINE | 101590525 |
| 200006496 | 200014889 | 1.86 | 98.6 | Palliative (P) | 2018-03-08 | 2018-03-23 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101802371 |
| 200006498 | 200014890 | 1.82 | 69 | Adjuvant (A) | null | 2018-10-01 | Ipilimumab | null | null | IPILIMUMAB | 101504084 |
| 200006499 | 200014891 | 1.77 | 62 | Palliative (P) | 2018-01-20 | 2018-01-20 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100485505 |
| 200006500 | 200014892 | 1.69 | 70.4 | Palliative (P) | null | 2021-11-14 | null | null | N | VEMURAFENIB | 101252769 |
| 200006501 | 200014893 | 1.53 | 75.2 | Palliative (P) | 2016-09-08 | 2016-09-13 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100834433 |
| 200006503 | 200014895 | 1.84 | 131 | Adjuvant (A) | null | 2019-06-07 | null | null | null | CLADRIBINE | 100484362 |
| 200006505 | 200014896 | null | 139.7 | 03 | 2017-10-20 | 2017-10-30 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101735727 |
| 200006513 | 200014901 | 1.62 | 84 | Palliative (P) | null | 2020-09-19 | DABRAFENIB | 2 | null | DABRAFENIB | 100174790 |
| 200006514 | 200014902 | 1.72 | 50.2 | Palliative (P) | 2016-09-30 | 2016-09-30 | DABRAFENIB | 02 | null | DABRAFENIB | 101460095 |
| 200006519 | 200014906 | null | null | null | 2020-05-28 | 2020-05-28 | null | 2 | null | IPILIMUMAB + NIVOLUMAB | 101273011 |
| 200006520 | 200014907 | null | 111 | Palliative (P) | 2018-11-04 | 2018-11-20 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100263842 |
| 200006522 | 200014909 | 1.76 | 74.6 | Palliative (P) | 2018-08-18 | 2018-09-14 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101722528 |
| 200006525 | 200014912 | null | null | null | null | 2020-02-27 | null | null | null | DACARBAZINE | 100717939 |
| 200006526 | 200014913 | 1.71 | 76 | null | 2021-05-09 | 2021-06-04 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100355235 |
| 200006527 | 200014914 | 1.74 | 83 | Palliative (P) | 2016-03-14 | 2016-04-11 | Binimetinib + Encorafenib | N | null | DABRAFENIB | 100310108 |
| 200006528 | 200014915 | 1.61 | 84.7 | null | 2018-09-03 | 2018-09-03 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101168052 |
| 200006530 | 200014917 | 1.63 | null | Curative (C) | null | 2019-12-14 | null | null | N | TALIMOGENE LAHERPAREPVEC | 100707139 |
| 200006532 | 200014918 | 1.73 | 91.2 | null | 2017-10-25 | 2018-01-18 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100430484 |
| 200006534 | 200014919 | 0 | 0 | Palliative (P) | 2019-04-12 | 2019-04-12 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101539125 |
| 200006538 | 200014922 | null | 123.4 | null | 2020-04-26 | 2020-06-21 | Rituximab | N | null | DABRAFENIB | 101570369 |
| 200006545 | 200014925 | null | 77.6 | Palliative (P) | 2017-07-16 | 2018-04-04 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101514756 |
| 200006548 | 200014928 | 1.65 | 82.6 | 02 | 2022-04-30 | 2022-04-30 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100328187 |
| 200006549 | 200014929 | 1.68 | 97.8 | 03 | 2019-12-09 | 2019-12-25 | Ipilimumab | 02 | null | IPILIMUMAB | 100127364 |
| 200006552 | 200014930 | null | 101 | Palliative (P) | 2019-09-04 | 2019-09-26 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100307463 |
| 200006554 | 200014932 | null | 70 | Palliative (P) | 2018-01-24 | 2018-01-30 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100437880 |
| 200006556 | 200014933 | 0 | 0 | Palliative (P) | 2021-08-15 | 2021-08-19 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101184349 |
| 200006559 | 200014935 | 1.61 | 74.5 | Palliative (P) | 2019-06-25 | 2019-07-07 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101348318 |
| 200006560 | 200014936 | 1.56 | 78.4 | null | 2017-02-07 | 2017-08-07 | Ipilimumab | 02 | null | IPILIMUMAB | 101159395 |
| 200006561 | 200014937 | 1.64 | 75 | Palliative (P) | 2018-06-04 | 2018-06-04 | TALIMOGENE LAHERPAREPVEC | 01 | null | TRIAL UNSPECIFIED | 100471139 |
| 200006567 | 200014940 | 1.66 | 94.25 | Palliative (P) | null | 2019-12-19 | null | null | N | LIPOSOMAL DOXORUBICIN | 101267686 |
| 200006579 | 200014947 | 1.66 | 81.8 | 03 | 2018-10-05 | 2018-10-06 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101036055 |
| 200006580 | 200014948 | 1.75 | 99.1 | Palliative (P) | 2020-02-11 | 2020-02-19 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100451821 |
| 200006582 | 200014949 | null | 104 | Palliative (P) | null | 2018-12-12 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 101258734 |
| 200006584 | 200014951 | 1.87 | 51.5 | Palliative (P) | 2021-07-24 | 2021-11-17 | Ipilimumab | null | null | IPILIMUMAB | 101155376 |
| 200006585 | 200014952 | 1.56 | null | Palliative (P) | 2016-06-29 | 2016-07-06 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100221601 |
| 200006587 | 200014953 | 1.66 | 104 | Palliative (P) | 2019-07-05 | 2019-08-30 | IPILIMUMAB + NIVOLUMAB | 02 | null | DABRAFENIB | 100894045 |
| 200006589 | 200014954 | null | 67 | Palliative (P) | 2019-01-19 | 2019-01-19 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100157009 |